SEC Form 4 · accession 0001209191-17-016813
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Tartol
Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | M | 13,064 | $22.94 | A | 201,486 | D | |
| Common Stock | Feb 28, 2017 | D | 5,306 | $56.49 | D | 196,180 | D | |
| Common Stock | Mar 2, 2017 | S | 2,758 | $56.48 | D | 193,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $22.94 | Feb 28, 2017 | M | 13,064 | D | Apr 15, 2011 | May 7, 2017 | Common Stock | 13,064 | 0 | D |
Explanation of responses
- F1The reporting person received 7,758 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,306 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on February 28, 2017 of $56.49 and sold 2,758 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise.